Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV004592280 | SCV005078496 | uncertain significance | not provided | 2024-04-29 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); Deletion involving a gene for which loss of function is not a known mechanism of disease; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV004592280 | SCV005697373 | pathogenic | not provided | 2024-10-10 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg325*) in the POLG2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in POLG2 are known to be pathogenic (PMID: 28078310, 29625556). This variant is present in population databases (no rsID available, gnomAD no frequency). This variant has not been reported in the literature in individuals affected with POLG2-related conditions. For these reasons, this variant has been classified as Pathogenic. |